• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射吸毒者中人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒的合并感染

Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.

作者信息

Devi Kh Sulochana, Brajachand Ng, Singh H Lokhendro, Singh Y Manihar

机构信息

Department of Microbiology, RIMS, Imphal.

出版信息

J Commun Dis. 2005 Mar;37(1):73-7.

PMID:16637404
Abstract

Injecting drug users (IDUs) are at risk of parenterally transmitted diseases such as hepatitis B virus (HBV) hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. The present study was undertaken to find out the prevalence of HIV infection, HBV infection and HCV infection among IDUs of a deaddiction centre. Serum samples from 250, injecting drug users (IDUs) from a de-addiction centre were screened for HBsAg using immunochromatography, anti HCV antibody by 3rd generation ELISA test and anti HIV antibody by ELISA test and immunochromatographic rapid test during the period August to October 2002. One hundred and forty-nine (59.6%) IDUs were positive for HIV antibody, 226 (90.4%) were positive for anti HCV antibody and 27 (10.8%) were positive for HBsAg. There was co-infection of HIV, HBV and HCV in 15 (6%) of the IDUs. The Co-infection of HBV and HCV were found in 12 cases (4.8%) and Co-infection of HIV and HCV was found in 131 cases (52.4%). The IDUs were in sexually active age group with a risk of infection to their sexual partner. There is high prevalence of HCV and HIV infection and co-infection of both viruses among IDUs. Comprehensive public health interventions targeting this population and their sexual partners must be encouraged. Increase coverage of needle, syringe exchange programme (NSEP) to young and new IDUs is required before they are exposed to blood borne viruses.

摘要

注射吸毒者有感染经肠道外传播疾病的风险,如感染乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)。本研究旨在查明戒毒中心注射吸毒者中HIV感染、HBV感染和HCV感染的流行情况。2002年8月至10月期间,对一家戒毒中心的250名注射吸毒者的血清样本进行了检测,采用免疫层析法检测HBsAg,采用第三代酶联免疫吸附试验检测抗HCV抗体,采用酶联免疫吸附试验和免疫层析快速检测法检测抗HIV抗体。149名(59.6%)注射吸毒者HIV抗体呈阳性,226名(90.4%)抗HCV抗体呈阳性,27名(10.8%)HBsAg呈阳性。15名(6%)注射吸毒者同时感染了HIV、HBV和HCV。发现12例(4.8%)同时感染HBV和HCV,131例(52.4%)同时感染HIV和HCV。这些注射吸毒者处于性活跃年龄组,有感染其性伴侣的风险。注射吸毒者中HCV和HIV感染以及两种病毒的合并感染率很高。必须鼓励针对这一人群及其性伴侣的全面公共卫生干预措施。在年轻和新的注射吸毒者接触血源病毒之前,需要扩大针具和注射器交换计划(NSEP)的覆盖范围。

相似文献

1
Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.注射吸毒者中人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒的合并感染
J Commun Dis. 2005 Mar;37(1):73-7.
2
Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.注射吸毒者中人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒的合并感染
J Indian Med Assoc. 2009 Mar;107(3):144, 146-7.
3
HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.伊朗德黑兰注射吸毒者中的 HIV、丙型肝炎病毒和乙型肝炎病毒合并感染。
Int J Infect Dis. 2010 Jan;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. Epub 2009 May 21.
4
Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.通过性传播感染艾滋病毒患者中隐匿性乙型和丙型肝炎的患病率。
Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.
5
Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.俄罗斯陶里亚蒂市注射吸毒者中的丙型肝炎病毒感染、艾滋病毒合并感染及相关风险
Int J STD AIDS. 2005 Nov;16(11):749-54. doi: 10.1258/095646205774763180.
6
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.意大利监狱服刑人员中HIV、HBV和HCV感染的相关因素:一项多中心研究的结果
J Med Virol. 2005 Jul;76(3):311-7. doi: 10.1002/jmv.20375.
7
Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.印度北部旁遮普邦阿姆利则市三组艾滋病毒感染高危人群中人类免疫缺陷病毒(HIV)、乙型肝炎病毒和丙型肝炎病毒的流行情况。
Jpn J Infect Dis. 2008 Jan;61(1):79-81.
8
Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.孟加拉国吸毒者中乙型肝炎病毒、丙型肝炎病毒和人类免疫缺陷病毒感染的患病率及危险因素
J Health Popul Nutr. 2000 Dec;18(3):145-50.
9
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.模拟英格兰和威尔士注射吸毒者中乙型肝炎和丙型肝炎的感染力。
BMC Infect Dis. 2006 Jun 8;6:93. doi: 10.1186/1471-2334-6-93.
10
Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.静脉注射吸毒者尸检材料中多种肝炎病毒感染的证据。
Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.

引用本文的文献

1
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.桑给巴尔注射毒品者中的艾滋病毒与乙型和丙型肝炎合并感染情况。
BMC Public Health. 2017 Nov 28;17(1):917. doi: 10.1186/s12889-017-4933-0.
2
HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.注射吸毒者中的艾滋病毒、乙型肝炎和丙型肝炎:在印度德里观察到艾滋病毒和丙型肝炎病毒RNA阳性感染的高流行率。
BMC Public Health. 2015 Jul 30;15:726. doi: 10.1186/s12889-015-2003-z.
3
Tackling the Hepatitis B Disease Burden in India.
应对印度的乙肝疾病负担
J Clin Exp Hepatol. 2014 Dec;4(4):312-9. doi: 10.1016/j.jceh.2014.12.004. Epub 2014 Dec 15.
4
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.印度国家肝脏研究协会(INASL)丙型肝炎病毒特别工作组共识声明。第一部分:印度丙型肝炎病毒感染现状报告。
J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 9.
5
Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency viruses amongst Injecting Drug Users in Mumbai,India.印度孟买注射吸毒者中乙型肝炎、丙型肝炎和人类免疫缺陷病毒的血清流行率。
J Clin Diagn Res. 2014 Jun;8(6):DL01-2. doi: 10.7860/JCDR/2014/7959.4482. Epub 2014 Jun 20.
6
Overview of substance abuse and hepatitis C virus infection and co-infections in India.印度物质滥用和丙型肝炎病毒感染及合并感染概述。
J Neuroimmune Pharmacol. 2010 Dec;5(4):496-506. doi: 10.1007/s11481-010-9227-6. Epub 2010 Jun 19.
7
The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions.印度钦奈注射吸毒者人群特征:风险行为的识别及其对干预措施的意义。
Subst Use Misuse. 2010 Feb;45(3):354-67. doi: 10.3109/10826080903452447.
8
Bloodborne viral hepatitis infections among drug users: the role of vaccination.吸毒者中的血源病毒性肝炎感染:疫苗接种的作用。
Int J Environ Res Public Health. 2009 Jan;6(1):400-13. doi: 10.3390/ijerph6010400. Epub 2009 Jan 22.
9
Hepatitis C in India.印度的丙型肝炎。
J Biosci. 2008 Nov;33(4):465-73. doi: 10.1007/s12038-008-0065-0.